Pulmatrix (PULM) Operating Margin: History & Chart

Pulmatrix, Inc.(PULM)

Biotechnology · Framingham, MA

$1.43-0.05 (-3.38%)

Delayed quote: Oct 6, 2026, 1:45 PM EDT

About Pulmatrix, Inc.

Pulmatrix, Inc. (PULM) is a clinical-stage biotechnology firm focused on creating and advancing inhaled treatments. The company's primary goal is to address significant unmet medical needs in respiratory and other diseases within the United States. Central to their approach is the innovative iSPERSE (inhaled small particles easily respirable and emitted) technology. This proprietary platform allows for the precise delivery of both small and large molecule therapeutics directly into the lungs, achieving either localized effects or systemic distribution throughout the body. Pulmatrix's development pipeline includes several key candidates: Pulmazole: An inhaled antifungal drug being developed to treat allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis. PUR1800: A narrow spectrum kinase inhibitor currently undergoing Phase 1b clinical trials for individuals suffering from stable moderate-to-severe chronic obstructive pulmonary disease (COPD). PUR3100: An iSPERSE-formulated version of dihydroergotamine, intended for the rapid relief of acute migraine attacks. The company also maintains strategic collaborations, including a licensing arrangement with RespiVert Ltd. for access to a range of kinase inhibitor drug candidates, a partnership with Cipla Technologies LLC for the development and commercialization of Pulmazole, and a collaboration and license agreement with Sensory Cloud, Inc. Established in 2003, Pulmatrix, Inc. is headquartered in Lexington, Massachusetts.

Framingham, MA

2 employees

www.pulmatrix.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Peter Ludlum

View full financials

PULM Operating Margin Metrics

OPERATING MARGIN

0.00%

OPERATING MARGIN AVG TTM

0.00%

OPERATING MARGIN AVG 3Y

-82.70%

OPERATING MARGIN AVG 5Y

-253.05%

OPERATING MARGIN AVG 10Y

-182.67%

OPERATING MARGIN AVG 15Y

-246.81%

OPERATING MARGIN AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

+100.00%

CURRENT VS 5Y AVG

+100.00%

CURRENT VS 10Y AVG

+100.00%

CURRENT VS 15Y AVG

+100.00%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

0.00%

median of 845 covered companies

CURRENT VS SECTOR MEDIAN

N/A

vs the sector median at left

NAME	MARKET CAP	OPERATING MARGIN	TTM	3Y	5Y
Pulmatrix, Inc. (PULM)	$5.22M	0.00%	0.00%	-82.70%	-253.05%
Gelteq Limited Ordinary Shares (GELS)vs ›	$5.20M	-3317.65%	-1658.83%	-2341.84%	-1561.23%
Lunai Bioworks Inc. (LNAI)vs ›	$5.21M	0.00%	0.00%	0.00%	0.00%
Intelligent Bio Solutions Inc. (INBS)vs ›	$5.24M	-305.03%	-323.91%	-495.10%	-376.97%
Alzamend Neuro Inc (ALZN)vs ›	$5.29M	0.00%	0.00%	0.00%	0.00%
Soligenix, Inc. (SNGX)vs ›	$5.35M	0.00%	0.00%	-1423.89%	-7655.73%
Basel Medical Group Ltd Ordinary Shares (BMGL)vs ›	$5.03M	-19.28%	1.28%	11.60%	11.60%
Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs ›	$5.00M	0.00%	0.00%	0.00%	0.00%
Imunon, Inc. (IMNN)vs ›	$5.02M	0.00%	0.00%	-1246.08%	-2147.17%
Lexaria Bioscience Corp. (LEXX)vs ›	$5.02M	-1683.01%	-1461.09%	-2100.59%	-1711.35%

NAME

MARKET CAP

OPERATING MARGIN

TTM

Pulmatrix, Inc. (PULM)

$5.22M

0.00%

-82.70%

-253.05%

Gelteq Limited Ordinary Shares (GELS)vs ›

$5.20M

-3317.65%

-1658.83%

-2341.84%

-1561.23%

Lunai Bioworks Inc. (LNAI)vs ›

$5.21M

0.00%

Intelligent Bio Solutions Inc. (INBS)vs ›

$5.24M

-305.03%

-323.91%

-495.10%

-376.97%

Alzamend Neuro Inc (ALZN)vs ›

$5.29M

0.00%

Soligenix, Inc. (SNGX)vs ›

$5.35M

0.00%

-1423.89%

-7655.73%

Basel Medical Group Ltd Ordinary Shares (BMGL)vs ›

$5.03M

-19.28%

1.28%

11.60%

Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs ›

$5.00M

0.00%

Imunon, Inc. (IMNN)vs ›

$5.02M

0.00%

-1246.08%

-2147.17%

Lexaria Bioscience Corp. (LEXX)vs ›

$5.02M

-1683.01%

-1461.09%

-2100.59%

-1711.35%

Operating Margin FAQ

What is the operating margin for Pulmatrix, Inc. (PULM)?

The operating margin for PULM stock is 0.00%.

Is Pulmatrix, Inc.'s operating margin high or low?

The operating margin of 0.00% is 100% above its 5-year average of -253.05%, near the high end of its 5-year range (-65066.67%–12.69%).

What is the TTM average operating margin for Pulmatrix, Inc. (PULM)?

The TTM average operating margin for PULM stock is 0.00%.

What is the 3Y average operating margin for Pulmatrix, Inc. (PULM)?

The 3Y average operating margin for PULM stock is -82.70%.

What is the 5Y average operating margin for Pulmatrix, Inc. (PULM)?

The 5Y average operating margin for PULM stock is -253.05%.

What is the 10Y average operating margin for Pulmatrix, Inc. (PULM)?

The 10Y average operating margin for PULM stock is -182.67%.

What is the 15Y average operating margin for Pulmatrix, Inc. (PULM)?

The 15Y average operating margin for PULM stock is -246.81%.

DATE	OPERATING MARGIN
2026-06-30	0.00%
2026-03-31	0.00%
2025-12-31	0.00%
2025-09-30	0.00%
2025-06-30	0.00%
2025-03-31	0.00%
2024-12-31	-65066.67%
2024-09-30	-725.96%
2024-06-30	-380.22%
2024-03-31	12.69%
2023-12-31	-101.04%
2023-09-30	-224.70%
2023-06-30	-216.43%
2023-03-31	-305.87%
2022-12-31	-253.22%
2022-09-30	-272.44%
2022-06-30	-342.52%
2022-03-31	-427.84%
2021-12-31	-886.62%
2021-09-30	-766.14%
2021-06-30	-170.76%
2021-03-31	-293.88%
2020-12-31	-133.70%
2020-09-30	-29.21%
2020-06-30	-33.54%
2020-03-31	-171.51%
2019-12-31	-244.04%
2019-09-30	-261.45%
2019-06-30	-164.91%
2019-03-31	0.00%
2018-12-31	0.00%
2018-09-30	0.00%
2018-06-30	0.00%
2018-03-31	-3342.48%
2017-12-31	0.00%
2017-09-30	-1284.78%
2017-06-30	0.00%
2017-03-31	0.00%
2016-12-31	-6374.36%
2016-09-30	-4911.48%
2016-06-30	-3450.00%
2016-03-31	-1374.49%
2015-12-31	-1561.45%
2015-09-30	-715.98%
2015-06-30	-6658.24%
2015-03-31	-2616.19%
2014-12-31	-516.88%
2014-09-30	-8646.67%
2014-06-30	0.00%
2014-03-31	-30137.50%
2013-12-31	0.00%
2013-09-30	0.00%
2013-06-30	0.00%
2013-03-31	0.00%
2012-12-31	0.00%
2012-09-30	0.00%
2012-06-30	0.00%

DATE

OPERATING MARGIN

2026-06-30

0.00%

2026-03-31

0.00%

2025-12-31

0.00%

2025-09-30

0.00%

2025-06-30

0.00%

2025-03-31

0.00%

2024-12-31

-65066.67%

2024-09-30

-725.96%

2024-06-30

-380.22%

2024-03-31

12.69%

2023-12-31

-101.04%

2023-09-30

-224.70%

2023-06-30

-216.43%

2023-03-31

-305.87%

2022-12-31

-253.22%

2022-09-30

-272.44%

2022-06-30

-342.52%

2022-03-31

-427.84%

2021-12-31

-886.62%

2021-09-30

-766.14%

2021-06-30

-170.76%

2021-03-31

-293.88%

2020-12-31

-133.70%

2020-09-30

-29.21%

2020-06-30

-33.54%

2020-03-31

-171.51%

2019-12-31

-244.04%

2019-09-30

-261.45%

2019-06-30

-164.91%

2019-03-31

0.00%

2018-12-31

0.00%

2018-09-30

0.00%

2018-06-30

0.00%

2018-03-31

-3342.48%

2017-12-31

0.00%

2017-09-30

-1284.78%

2017-06-30

0.00%

2017-03-31

0.00%

2016-12-31

-6374.36%

2016-09-30

-4911.48%

2016-06-30

-3450.00%

2016-03-31

-1374.49%

2015-12-31

-1561.45%

2015-09-30

-715.98%

2015-06-30

-6658.24%

2015-03-31

-2616.19%

2014-12-31

-516.88%

2014-09-30

-8646.67%

2014-06-30

0.00%

2014-03-31

-30137.50%

2013-12-31

0.00%

2013-09-30

0.00%

2013-06-30

0.00%

2013-03-31

0.00%

2012-12-31

0.00%

2012-09-30

0.00%

2012-06-30

0.00%

Operating Margin: 0.00%

PULM Operating Margin

PULM Average Operating Margin Chart

PULM Current vs Average Operating Margin Chart

PULM Operating Margin Metrics

PULM Competitors' Operating Margin

Operating Efficiency

Operating Margin Formula & Definition

Operating Margin FAQ

PULM Operating Margin History

Related Metrics